Buscar resultados de ensayos clínicos
Lymphoma, T-Cell, Cutaneous - 27 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) Condición: Cutaneous T Cell Lymphoma Fecha: 2012-07-15 Intervenciones:
|
Completed |
Nombre del estudio: Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2006-03-23 Intervenciones:
|
Completed |
Nombre del estudio: A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) Condición: Cutaneous T-cell Lymphoma Fecha: 2005-03-24 Intervenciones: Drug: romidepsin (depsipeptide, FK228) Study patients received romidepsin at a dose of 14 mg/m^2 intrave |
Recruiting |
Nombre del estudio: Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) Condición: Cutaneous T-Cell Lymphoma Fecha: 2015-10-29 Intervenciones: Biological: IPH4102 |
Recruiting |
Nombre del estudio: Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) Condición: Cutaneous T Cell Lymphoma Fecha: 2015-09-06 Intervenciones: Drug: dimethylfumarate dose escalation from 30 mg/d to 720 mg/d over 9 weeks following a preset design i |
NOT_YET_RECRUITING |
Nombre del estudio: A Safety Study of SGN-35T in Adults With Advanced Cancers Condición: Lymphoma, T-Cell, Cutaneous Fecha: 2024-05-19 Intervenciones: Given into the vein (IV; intravenously) |
RECRUITING |
Nombre del estudio: Tissue Repository: CTCL Collection Protocol Condición: Lymphoma, T-Cell, Cutaneous Fecha: 2024-05-19 |